Skip to main content

Table 1 Demographic data and intraoperative data of the enrolled patients

From: Effect of erector spinae plane block with different doses of dexmedetomidine as adjuvant for ropivacaine on the postoperative quality of recovery after video-assisted thoracoscopic lobectomy surgery: a randomized controlled trial

 

Group R

Group RD1

Group RD2

Age(yr)

52.9 ± 8.7

53.6 ± 7.7

50.9 ± 10.6

Height(cm)

163.5 ± 5.8

162.7 ± 6.2

164.7 ± 5.3

Weight(kg)

63.0 ± 6.3

58.5 ± 7.1

62.0 ± 8.1

BMI(kg/m2)

23.7 ± 1.8

23.1 ± 2.7

23.0 ± 2.5

Gender(n, M/F)

18/20

19/21

21/18

ASAclass(I-II)

16/22

20/20

17/22

Surgical side(right/left)

21/17

18/22

20/19

Operation time(min)

119.5 ± 10.6

123.8 ± 15.3

122.3 ± 16.7

Consumption of sufentanil (µg)

55.6 ± 5.3

53.2 ± 4.7

51.9 ± 4.8

Consumption of remifentanil (µg)

713.4 ± 65.5

700.6 ± 63.7

688.9 ± 60.2

  1. Note: Data are presented as the mean ± standard deviation (SD) or as the number of the patients, as appropriate
  2. Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index; Group R = Group ropivacaine; Group RD1 = Group ropivacaine plus 0.5 µg/kg dexmedetomidine; Group RD2 = Group ropivacaine plus 1.0 µg/kg dexmedetomidine;